Avidity Biosciences, Inc. Common Stock
RNAM
XNAS
•
PHARMACEUTICAL PREPARATIONS
Market Cap
11B
Borrow Fee
0.28%
Available Shares
0
Price Chart
Company Overview
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. The company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
Company Info
Exchange:
NASDAQ
Industry:
PHARMACEUTICAL PREPARATIONS
CIK:
0001599901
Asset Type:
CS
Market Data
Market Cap:
$11,249,151,386
Employees:
391
Status:
Active
Short Interest
Current Borrow Fee
0.28%
Range: 0.28% -
0.28%
Available Shares
0
Range: 0 -
0
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.